Bcor

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bcor

Property Description
Active ingredient Bisoprolol (as Bisoprolol fumarate)
Form Oral tablets
Pharmacological class Cardioselective Beta-blocker
General purpose Supports healthy cardiovascular stability
Origin Synthetic compound

What is Bcor and Its Pharmacological Class?

Bcor is a prescription-only medicine whose single active ingredient is Bisoprolol, structured as Bisoprolol fumarate. This pharmaceutical product is manufactured as an oral preparation in the form of tablets. The medication is classified as a cardioselective beta-adrenoceptor antagonist, commonly known as a beta-blocker. This classification confirms the drug's role in modulating heart activity. Bcor is clinically recognized for its high selectivity, offering a specialized effect compared to non-selective agents in the same class.


Composition and Origin of Bisoprolol Fumarate

The active core of Bcor is Bisoprolol fumarate, a highly defined synthetic compound created through controlled chemical synthesis. Unlike some substances derived from biological sources, its synthetic origin ensures a consistent purity and reliable concentration of the active ingredient within every tablet. Bisoprolol is used to block the effects of certain natural substances on the heart and blood vessels. Bcor's formulation is typical of this class and is often initiated in adults who require sustained, once-daily management. It is a single-ingredient product, containing only Bisoprolol fumarate alongside necessary solid pharmaceutical excipients—non-active materials—that provide the structure required for oral ingestion.


How Does Bcor Generally Help the Cardiovascular System?

Bcor generally provides a calming effect on the heart to promote more efficient cardiac output and systemic stability. Its function is achieved through the selective blockade of beta1-adrenergic receptors. This mechanism prevents certain stress signals from stimulating the heart, thereby reducing its workload. The resultant general benefit stems from two key mechanism principles: inducing a controlled heart rate slowing and achieving a force reduction in the heart muscle's contractions, which supports the overall stabilization of the cardiovascular system.

Regulatory References

  1. MedlinePlus

What side effects are possible with Bcor?

Official Regulatory Safety Profile

This information details the officially documented adverse effects and safety considerations for Amoxicillin, strictly based on government regulatory sources (e.g., FDA, EMA).

Serious Adverse Reactions and Contraindications

The most critical risk is hypersensitivity to penicillin-class drugs, which can lead to life-threatening reactions such as anaphylaxis and warrants avoiding the medicine entirely if an allergy is known. Other serious events include Clostridioides difficile-associated diarrhea (CDAD) (colitis), rare but severe skin reactions known as SCARs (e.g., SJS, TEN, DRESS), and Drug-Induced Enterocolitis Syndrome (DIES).

Adverse Reaction Type Examples (Documented)
Common (Reported 1.0%) Diarrhea, Nausea, Vomiting, Headache, Vulvovaginal Mycotic Infection
System-Organ Class Gastrointestinal, Blood and Lymphatic System, Nervous System, Skin, Hepatobiliary, Renal
Hematologic Hemolytic anemia, thrombocytopenia, eosinophilia
Neurologic Agitation, confusion, reversible hyperactivity, convulsions

Population and Drug Safety Notes

Specific caution is advised for patients with renal impairment, often requiring dose adjustment, as this increases the risk of convulsions and crystalluria (kidney crystal formation). The medicine should be avoided in patients suspected of having infectious mononucleosis due to a high risk of developing a non-allergic rash. Co-administration with Allopurinol may increase the risk of skin rash. Amoxicillin may also reduce the effectiveness of oral hormonal contraceptives, and can potentially prolong prothrombin time when used with oral anticoagulants.

Overdose and Emergency Response

A suspected overdose of Bcor (Bisoprolol fumarate) requires immediate medical attention due to the risk of severe cardiovascular and systemic manifestations. Regulatory information indicates that the overdose profile is defined by an exaggerated form of the medication’s known pharmacological effects.

Documented overdose presentations include pronounced bradycardia (excessively slow heart rate) and hypotension (low blood pressure). Further documented signs are the precipitation of congestive heart failure, acute bronchospasm, and metabolic disturbance in the form of hypoglycemia. Life-threatening outcomes, such as second or third degree AV block (a serious heart conduction disturbance), may also occur.

In all cases of overdosage, regulatory labels mandate that Bisoprolol fumarate therapy must be stopped immediately. Management focuses on symptomatic and supportive treatment, which is required to correct specific physiological disturbances. This management may include the administration of intravenous atropine for bradycardia, IV fluids and pressors for severe hypotension, and conventional therapy for heart failure. The intervention for life-threatening AV block includes IV isoproterenol or, if necessary, the insertion of a transvenous cardiac pacemaker. Furthermore, the regulatory profile notes that Bisoprolol is not dialyzable, confirming that emergency care must concentrate on specific supportive interventions for each manifestation.

Therapeutic Uses of Bcor

Main Uses of Bcor

Bcor is primarily utilized as a selective beta-blocker, specifically targeting the beta-1 adrenergic receptors located in the heart. By modulating the response to certain nerve impulses, it helps manage several cardiovascular conditions effectively.

Hypertension (High Blood Pressure)

The most common application of Bcor is the management of hypertension. It works by reducing the heart rate and the force of contraction, which lowers the overall pressure within the blood vessels. Consistently managing blood pressure is a key factor in reducing the long-term risk of cardiovascular complications.

Angina Pectoris (Chest Pain)

Bcor is used to prevent chronic stable angina. In patients with this condition, the heart muscle does not receive enough oxygen-rich blood during physical activity or stress. By decreasing the heart's workload and oxygen demand, the medication helps reduce the frequency and severity of chest pain episodes.

Heart Failure

In specific clinical settings, Bcor is integrated into the management of stable, chronic heart failure. It is used to improve the heart's pumping efficiency over time and to help stabilize the cardiac rhythm.


Clinical Benefits

  • Cardiac Protection: By slowing the heart rate, Bcor allows the heart to fill more efficiently and reduces strain on the cardiac muscle.
  • Selectivity: As a cardioselective agent, Bcor primarily affects the heart while having a minimal impact on the respiratory airways at standard therapeutic doses.
  • Consistency: The pharmacological profile of Bcor allows for stable blood levels, providing steady management of symptoms throughout the day.

Eligibility and Restrictions for Use

Eligibility Profile: Official Regulatory Information

This section outlines who must not use Bisoprolol Fumarate and for whom use is restricted, based strictly on authoritative government regulatory documents (e.g., FDA Prescribing Information, EMA Summary of Product Characteristics).

Contraindicated Populations (Must NOT Use)

  • Patients with hypersensitivity to the active substance or any excipients.
  • Individuals experiencing acute heart failure or cardiogenic shock.
  • Patients with specific severe heart rhythm disorders, such as second or third degree AV block (without a pacemaker), sick sinus syndrome, or sinoatrial block.
  • Individuals with symptomatic bradycardia (very slow heart rate) or symptomatic hypotension (very low blood pressure).
  • Patients with severe bronchial asthma or severe chronic obstructive pulmonary disease (COPD).
  • Individuals with untreated phaeochromocytoma or metabolic acidosis.

Populations for Whom Use is Not Recommended or Restricted

  • Paediatric population (children and adolescents under 18 years) due to a lack of established safety and efficacy data.
  • Pregnant and breastfeeding women; use is generally not recommended due to potential risks to the foetus or infant.
  • Patients with severely impaired renal or hepatic function, for whom use may be restricted, especially in treating heart failure.

This structure reflects the regulatory mandate to exclude specific populations where the risk significantly outweighs the benefit or where data is insufficient, thereby defining the official boundaries of the eligible patient population.

What should I know about interactions with other medicines?

Bcor Interactions with other medicines and products

The interaction profile for Bcor (Bisoprolol) is primarily defined by the potential for pharmacodynamic reinforcement with other cardiovascular agents. Co-administration with other beta-blocking agents is contraindicated due to the high risk of additive effects on heart rate and blood pressure.

Specific classes of medicines require careful regulatory consideration:

  • Calcium Antagonists of the Verapamil and Diltiazem types, as well as Antiarrhythmic Agents (e.g., Disopyramide), are associated with an enhanced risk of myocardial depression and AV conduction inhibition.
  • Digitalis Glycosides and Catecholamine-Depleting Drugs (e.g., Reserpine) can lead to additive effects on heart rhythm, increasing the risk of bradycardia.
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs) may decrease Bcor's blood pressure-lowering effect due to pharmacodynamic antagonism.

A specific procedural restriction applies to withdrawal: if co-administered with Clonidine, Bcor must be discontinued for several days prior to the withdrawal of Clonidine.

In terms of pharmacokinetic interactions, Rifampin is documented to increase the metabolic clearance of Bisoprolol, resulting in a shortened elimination half-life and reduced systemic exposure. Formal studies confirm no clinically relevant pharmacokinetic interactions with Cimetidine or Warfarin, and the absorption of Bisoprolol is not affected by food.

Mechanism of Action

How BCOR Works

BCOR exerts its action via the targeted modulation of molecular signaling pathways within specific biological systems. The compound is designed to interact with mechanisms that influence cellular activity across distinct mechanistic domains, ultimately leading to altered pathway responses.


Modulation of Receptor-Mediated Signaling

BCOR functions as a selective antagonist at specific receptor sites, blocking the binding of endogenous transmitters and mediators. This interaction prevents the initiation of downstream signaling sequences by suppressing the activity of the receptor complex. The resulting molecular intervention modifies the initial steps of pathway activation, thereby regulating the flow of intracellular signals.


Influence on Physiological Feedback Loops

Beyond receptor antagonism, BCOR modulates key pathways involved in rapid physiological responses. The compound engages intracellular mechanisms that influence feedback regulation within these pathways. This downstream effect modifies the systemic integration of signals, thereby influencing overall physiological parameters and shaping the compound’s distinct pharmacodynamic activity profile.

Dosage and Administration Information

How to Use Bcor: Official Administration Guidelines

Bcor (Bisoprolol) is prescribed for long-term treatment and its usage is defined by established guidelines to ensure a standardized administration approach. The medicine is approved for oral intake as a tablet, which must be swallowed whole with liquid and should not be chewed or crushed. It is typically administered once daily, preferably in the morning, and may be taken independently of food.


Standard Dosage and Frequency Patterns

The standard adult dosing regimens for Bcor vary based on the specific condition being managed:

Condition Starting Dose Maximum Daily Dose
Hypertension / Angina 5 mg once daily 20 mg once daily
Chronic Stable Heart Failure 1.25 mg once daily 10 mg once daily

For chronic stable heart failure, the initial dose is very low, requiring a gradual upward titration over a period of weeks or months to reach the optimal tolerated maintenance level, as outlined in the official treatment protocol.


Population-Specific Constraints and Discontinuation

Official instructions require specific dose constraints for certain patient groups. For individuals with severe renal or hepatic impairment being treated for hypertension or angina, the total daily dose is limited to a maximum of 10 mg. Use is generally not recommended in the pediatric population, as efficacy and safety have not been established. Furthermore, the protocol for discontinuing Bcor mandates a gradual reduction (tapering) over one to two weeks, making the manner of cessation a formal procedural requirement.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Bcor


Evidence for Use in Chronic Heart Failure (HFrEF)

The research foundation for Bcor in Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) includes large-scale, multi-center Randomized Controlled Trials (RCTs). These studies were conducted over intermediate periods (typically 1 to 3 years) and often compared Bisoprolol against a placebo. The patient population in these studies included adults with stable, symptomatic heart failure and who were also receiving established background therapy. The main outcomes that researchers focused on were crucial endpoints like the frequency of all-cause mortality and hospitalization due to the worsening of heart failure. Studies reported measurements of difference for the defined endpoints when comparing the groups that received the drug to those that received placebo.

Evidence for Use in Essential Hypertension (High Blood Pressure)

The research for Bcor in Essential Hypertension includes Randomized Controlled Trials (RCTs), some short-term (lasting 8 to 12 weeks), which compared it to placebo or other classes of antihypertensive agents. This research examined blood pressure control in adults with hypertension, including specific groups who also had co-existing conditions like Coronary Artery Disease (CAD). Studies monitored the main surrogate endpoint of changes in systolic and diastolic blood pressure and assessed the proportion of patients who reached a specific blood pressure goal. Research highlights measured changes in blood pressure control observed during the study period.


Long-Term Studies and Follow-up Duration

The research for Bcor has explored follow-up durations that vary depending on the condition being studied. For chronic heart failure, the pivotal trials included intermediate-term observation periods of 1 to 3 years, with some observational studies extending to 4 years or more to examine sustained findings. This section highlights that the drug was observed in long-term research settings but also clarifies that long-term data are not fully established or well-characterized across every possible indication and patient group. Research provides context but not individual predictions regarding the durability of findings over many years.


What is Still Uncertain About the Research for Bcor

There are several areas where the research evidence for Bcor remains limited or uncertain. Key gaps include the limited data on the drug’s role in Heart Failure with preserved Ejection Fraction (HFpEF) and the generally shorter follow-up durations for symptomatic control in angina compared to the definitive outcome trials for heart failure. Furthermore, data for certain groups remain insufficient; these include highly complex or unstable patients, who were often excluded from the controlled trial environment.

Frequently Asked Questions (FAQ)

Common questions about Bcor (FAQ)

Q: What exactly is Bcor used for, besides the main condition people talk about?

A: According to official regulatory documents, Bcor (bisoprolol) is indicated for the treatment of hypertension (high blood pressure) and angina pectoris (chest pain). Its third primary use is the management of stable chronic heart failure with reduced left ventricular systolic function.

Q: What are the most common side effects people report on forums for Bcor?

A: Official labeling documents report common side effects (occurring in 1% to 10% of patients) including gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation. Other effects classified as common in clinical trials include headache, fatigue, dizziness, and sleep disturbances like insomnia.

Q: Why would someone need to gradually stop taking Bcor instead of just stopping?

A: Official instructions mandate that discontinuing Bcor must be a gradual reduction (tapering), typically over one to two weeks. This procedure is required because abrupt withdrawal of the medication has been associated with a potential risk of worsening the underlying heart condition, which could include a sharp rise in blood pressure or exacerbation of angina symptoms.

Q: Is it normal to feel a little lightheaded when first taking Bcor?

A: Official regulatory documents list dizziness and lightheadedness as common side effects of Bcor. These effects are often related to the initial lowering of your heart rate and blood pressure as the medication starts working. Bradycardia (a slow heart rate) is also documented as a common occurrence.

Q: How does Bcor impact blood pressure, even if that's not its primary purpose?

A: Bcor is fundamentally a cardiovascular medicine and works by slowing the heart rate and reducing the force of heart contractions. This mechanism naturally contributes to a lowering of blood pressure, even when the drug is being used primarily to treat heart failure.

Q: How soon after stopping Bcor do its effects wear off?

A: The time it takes for a drug to be eliminated is measured by its plasma elimination half-life, which for Bcor is approximately 9 to 12 hours. This means it takes this length of time for half of the drug to be cleared from the system. The effects are generally considered sustained throughout the 24-hour dosing period.

Q: Are there any long-term side effects of taking Bcor for many years?

A: Bcor is intended for long-term use. However, data from studies with follow-up durations extending beyond a few years for all potential uses and patient groups are generally considered limited or not fully characterized in the official regulatory documents.

Q: Does Bcor affect laboratory test results, like cholesterol levels?

A: Studies and official information indicate that Bcor can affect certain laboratory parameters. These may include increases in uric acid, creatinine, blood urea nitrogen (BUN), glucose, and potassium levels. Changes to cholesterol levels have also been reported, specifically increases in triglycerides and decreases in 'good' cholesterol (HDL).

Q: Does Bcor interact with cold and flu medicines?

A: Bcor can interact with some cold and flu medicines that contain sympathomimetic agents—such as common decongestants. Taking Bcor alongside these products may lead to a significant increase in blood pressure and heart rate, which could counteract the blood pressure-lowering effect of Bcor.

Q: What's the main difference between Bcor and other common heart medications?

A: Bcor is classified as a cardioselective beta-blocker. This means that at therapeutic doses, it primarily blocks the beta-1 receptors found in the heart. This selective action helps to distinguish it from other agents in the same class that are non-selective, as well as from entirely different classes of cardiovascular drugs, such as calcium channel blockers.

Q: How quickly should I expect to feel a difference after starting Bcor?

A: After taking Bcor, the concentration of the drug in the bloodstream typically reaches its peak within 2 to 4 hours. For the treatment of hypertension, effects on blood pressure are generally observed within one week of initiating treatment.

Q: Does Bcor have a generic version available yet?

A: Yes, the active ingredient in Bcor is bisoprolol fumarate. According to regulatory records, this compound is widely available as a generic drug in the United States and other regions.

Q: Can Bcor cause weight gain or weight loss?

A: Official information reports weight changes as a common metabolic side effect (affecting 1% to 10% of users). Weight gain has also been reported in clinical trials as a potential sign that existing heart failure may be worsening.

Q: How does Bcor help improve blood flow or heart function?

A: Bcor helps the heart by reducing its workload. It achieves this by selectively blocking certain stress signals, which results in a slower heart rate and a decreased force of contraction. This mechanism helps to balance the heart's work and oxygen demand, thereby supporting overall cardiovascular function.

Q: Can Bcor affect sleep patterns or cause insomnia?

A: Official labeling reports that insomnia (difficulty sleeping) is a common side effect associated with Bcor use. Other nervous system side effects have been reported to include sleep disturbances and nightmares.

Q: Are there any specific foods or drinks I should avoid while on Bcor?

A: Official regulatory information indicates that Bcor's absorption is not affected by food. While no specific foods are forbidden, caution is advised with substances like alcohol, which can enhance the blood pressure-lowering effect of the medication.

Q: How long do I usually have to take Bcor before a doctor might adjust the dose?

A: For conditions like chronic heart failure, official guidelines state that dose adjustments, if needed and tolerated, are typically made at intervals of one to two weeks. This allows the healthcare provider to assess how the body is responding to the current dose.

Q: Can Bcor make you feel unusually tired or fatigued?

A: Fatigue (tiredness) and asthenia (a general lack of energy) are reported in official documents as very common side effects of Bcor. These effects are among the most frequently observed in patients initiating treatment.

Q: Is Bcor available as an injection or only as a tablet?

A: Bcor is exclusively supplied as an oral drug. It is manufactured only as tablets meant to be taken by mouth, and there is no approved injectable form of the product.

Q: Are there any vitamins or supplements that Bcor is known to interact with?

A: The labeling notes potential interactions with catecholamine-depleting drugs and other agents that slow the heart, which require close consideration due to the risk of additive effects. It is important to note that any substance that affects blood pressure, heart rate, or liver enzymes may have an effect.

Q: Does taking Bcor at a specific time of day make a difference?

A: Bcor is typically administered once daily. Official instructions state that the medication should preferably be taken in the morning. This timing helps establish a consistent routine to maintain the drug’s effectiveness throughout the day.

Q: Does Bcor interact with alcohol, and how severe is the interaction?

A: Alcohol consumption can lead to an additive effect with Bcor, meaning both substances work together to lower blood pressure. This effect can enhance the risk of side effects such as dizziness, lightheadedness, or fainting.

Q: How does Bcor affect the body's electrolyte balance?

A: Regulatory documents indicate that Bcor can cause minor alterations in the body's metabolism and electrolyte balance. Specifically, the drug has been documented to cause increases in serum potassium levels.

Q: Does Bcor cause any digestive issues like constipation or diarrhea?

A: Yes, Bcor can cause gastrointestinal side effects. Official reports list both diarrhea and constipation as common side effects (occurring in 1% to 10% of patients), along with other issues like nausea and vomiting.

Q: Can Bcor cause temporary blurred vision or changes in eyesight?

A: Official labeling reports that Bcor use can lead to visual disturbances. This may include blurred vision or, in some cases, changes related to reduced tear flow.

Q: Is Bcor often prescribed alongside other cardiovascular medications?

A: Bcor is commonly used as part of a combination treatment plan. In clinical trials for heart failure, patients receiving Bcor were often also taking established medications like ACE inhibitors and diuretics. This suggests Bcor is often used as a component of combination treatment.

Q: What do people mean when they say Bcor is a 'maintenance drug'?

A: Bcor is prescribed for long-term treatment of conditions such as hypertension and chronic heart failure. Being a 'maintenance drug' means it is intended for consistent, daily use over an extended period to sustain stability and manage the underlying condition.

Q: Are there any specific demographic groups (e.g., ethnic) that react differently to Bcor?

A: Clinical trial data has indicated that for the treatment of hypertension, blood pressure reductions were significantly greater in non-Black patients than in Black patients. This is a finding from clinical trials.

Q: Does Bcor have a risk of dependence or withdrawal symptoms?

A: Regulatory documents warn against abrupt cessation and require a gradual reduction (tapering) of the dose. The official reason for tapering is to prevent a rebound effect or worsening of the underlying condition.

Q: Can Bcor be taken with or without food?

A: The official administration instructions confirm that Bcor tablets can be taken with or without food. This is because the medication’s absorption is not significantly affected by the presence of food in the stomach.

Q: Does Bcor stay in your system for a long time after you stop taking it?

A: The plasma elimination half-life—the time it takes for the concentration to drop by half—is approximately 9 to 12 hours in healthy individuals.

Q: Why is Bcor sometimes described as having a 'novel mechanism' of action?

A: Bcor is classified as having a cardioselective beta1-adrenergic blocking agent (a type of beta-blocker). The selectivity of its action, primarily targeting beta1 receptors in the heart at low doses, provides a specialized effect.

How should Bcor be stored and disposed of?

The storage and disposal of Bcor (Bisoprolol fumarate) must strictly follow the conditions specified in the medicine's regulatory labeling to ensure product stability and safety.

Storage Requirements

Bcor tablets must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), with brief excursions permitted up to 30 C (86 F). The product must be kept in its original container, which should be tightly closed, and protected from excessive heat, moisture, and light. A crucial safety requirement is that Bcor must be kept out of the reach and sight of children.

Disposal Instructions

Unused or expired Bcor must be disposed of in accordance with local regulations and national disposal policies. Official instructions state that the medicine should not be disposed of via wastewater or household waste to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bcor found in:

A-Z Index: